People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| XCR Diagnostics Inc | — | Biotechnology | Seed | $2.4M | $79.9M | 2015 |
| Fluoresentric, Inc. | — | Biotechnology | Pre-Seed | $500K | $27.6M | 2014 |
Brian C Caplin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian C Caplin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William C Olson | 2 | 3 |
| Mark Bagnall | 1 | 3 |
| Mark C Bagnall | 1 | 1 |
| Ann Marie C Buoscio | 1 | 1 |
| Stephen C Caplin | 1 | 1 |
| Mark Powelson | 1 | 1 |
| Brian Caplin | 1 | 1 |
| Ann Marie Buoscio | 1 | 1 |
| Linda C Merrill | 1 | 1 |
| Linda Merrill | 1 | 1 |
| Mark C Powelson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.